Clinical Trial

Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated November 1, 2024 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, phase 3 randomized controlled clinical trial. Cervical cancer patients who undergo radical surgery but do not meet criteria of adjuvant therapy according to NCCN guideline are enrolled to receive adjuvant chemotherapy. The primary endpoint was disease-free survival (DFS) rate at 3 year. The secondary endpoints were 5-year DFS, overall survival (OS) and safety.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-01-21.
Status change: Recruiting → Active, Not Recruiting 2024-10-30
Trial Details
NCT Number NCT04723875
Lead Sponsor Huazhong University of Science and Technology
Collaborators: Women's Hospital School Of Medicine Zhejiang University, Qilu Hospital of Shandong University, Obstetrics & Gynecology Hospital of Fudan University, First Affiliated Hospital of Chongqing Medical University, Hunan Cancer Hospital, The Third Xiangya Hospital of Central South University
Conditions Uterine Cervical Neoplasms, Cervical Cancer
Enrollment 306 participants
Start Date 2021-01-28
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-01